Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Total 13F shares
-
111,338,432
-
Share change
-
-3,146,512
-
Total reported value
-
$1,100,040,141
-
Put/Call ratio
-
120%
-
Price per share
-
$9.88
-
Number of holders
-
123
-
Value change
-
-$44,224,810
-
Number of buys
-
57
-
Number of sells
-
59
Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2017
As of 31 Dec 2017,
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,338,432 shares.
The largest 10 holders included
Artal Group S.A., FMR LLC, BlackRock Inc., Ulys, L.L.C., UBS ASSET MANAGEMENT AMERICAS INC, Vanguard Group Inc, USS Investment Management Ltd, NEA Management Company, LLC, STATE STREET CORP, and CLEARBRIDGE, LLC.
This page lists
123
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.